Different Lipid Variables Predict Incident Coronary Artery Disease in Patients With Type 1 Diabetes With or Without Diabetic Nephropathy: The FinnDiane Study
Nina Tolonen(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Johan Wadén(Helsinki University Hospital), Carol Forsblom(University of Helsinki), Ville‐Petteri Mäkinen(Helsinki University Hospital), Daniel Gordin(Helsinki University Hospital), Niina Sandholm(University of Helsinki), Valma Harjutsalo(Research Council of Finland), Lena M. Thorn(University of Helsinki), Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Maija Feodoroff(University of Helsinki)
Cited by 32
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k